Effects of Sacubitril/Valsartan on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and the Role of Percentage of Delayed Enhancement Measured by Cardiac Magnetic Resonance in Predicting Therapeutic Response: A Multicentre Study

Background: This study aims to evaluate the cardiopulmonary effects of sacubitril/valsartan therapy in patients with heart failure with reduced ejection fraction (HFrEF), investigating a possible correlation with the degree of myocardial fibrosis, as assessed by cardiac magnetic resonance. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Nugara, Cinzia, Giallauria, Francesco, Vitale, Giuseppe, Sarullo, Silvia, Gentile, Giovanni, Clemenza, Francesco, Lo Voi, Annamaria, Zarcone, Antonino, Venturini, Elio, Iannuzzo, Gabriella, Coats, Andrew JS, Sarullo, Filippo M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326660/
https://www.ncbi.nlm.nih.gov/pubmed/37427008
http://dx.doi.org/10.15420/cfr.2022.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326660/
https://www.ncbi.nlm.nih.gov/pubmed/37427008
http://dx.doi.org/10.15420/cfr.2022.13

Ejemplares similares